Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz Life Insurance
you are here: HomeNewsIndia

Delhi Records 1,674 Fresh COVID-19 Cases In A Day, Positivity Rate Dips To 3.15%

Sixty-three more fatalities were recorded in a day, pushing the death toll in the national capital to 9,706, while the positivity rate dropped to 3.15 percent, the bulletin stated.

Dec 7, 2020 / 07:16 PM IST

Delhi recorded 1,674 fresh COVID-19 cases in a day while the positivity rate slipped to 3.15 percent on December 7, authorities said. These fresh cases were detected from 53,207 COVID-19 tests conducted the previous day, according to the latest bulletin issued by the Delhi health department.

Sixty-three more fatalities were recorded in a day, pushing the death toll in the national capital to 9,706, while the positivity rate dropped to 3.15 percent, the bulletin stated.

The positivity rate on Thursday, Friday, Saturday and Sunday was 4.96 percent, 4.78 percent, 4.2 percent and 3.68 percent respectively.

The tally of active cases on Monday dropped to 22,486 from 24,693 the previous day. The national capital had recorded 2706 fresh COVID-19 cases on Sunday.

The bulletin said that the total number of cases of coronavirus infection has climbed to 5,93,924.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Dec 7, 2020 07:16 pm
Sections